Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06301477

PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Children's Hospital of Eastern Ontario · Academic / Other
Sex
All
Age
8 Years – 16 Years
Healthy volunteers
Not accepted

Summary

To determine whether a specific food-origin plant-derived resistant starch (RS) optimized for the individual will increase the abundance of known butyrate producing microbes.

Conditions

Interventions

TypeNameDescription
OTHERResistant Starch7.5g/m2 or 5.0g/m2 (body surface area) resistant starch oral consumption
OTHERPlaceboPlacebo oral consumption of food-grade cornstarch

Timeline

Start date
2024-12-01
Primary completion
2025-12-08
Completion
2027-03-01
First posted
2024-03-08
Last updated
2026-01-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06301477. Inclusion in this directory is not an endorsement.

PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial (NCT06301477) · Clinical Trials Directory